Blue Owl Capital Holdings
Latest statistics and disclosures from Blue Owl Capital Holdings's latest quarterly 13F-HR filing:
- Top 5 stock holdings are HOOD, CGEM, PLRX, ENGN, TRML, and represent 44.41% of Blue Owl Capital Holdings's stock portfolio.
- Added to shares of these 10 stocks: ENGN (+$21M), EVCM (+$16M), SGMT (+$7.1M), LRMR, AQST, SLRN, MDGL, IKNA, TRML, BRZE.
- Started 7 new stock positions in ELVN, EVCM, MDGL, SNOW, Precision Biosciences, AQST, GTLB.
- Reduced shares in these 10 stocks: TOST (-$139M), KROS (-$12M), CGEM (-$8.4M), BPMC (-$6.6M), SYRS (-$6.2M), Orchard Therapeutics, Freeline Therapeutics Holdings, MLYS, MIRM, Precision Biosciences Ord.
- Sold out of its positions in BPMC, Freeline Therapeutics Holdings, MIRM, Orchard Therapeutics, Precision Biosciences Ord.
- Blue Owl Capital Holdings was a net seller of stock by $-101M.
- Blue Owl Capital Holdings has $501M in assets under management (AUM), dropping by 19.66%.
- Central Index Key (CIK): 0001858703
Tip: Access up to 7 years of quarterly data
Positions held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Blue Owl Capital Holdings
Blue Owl Capital Holdings holds 45 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Robinhood Mkts Com Cl A (HOOD) | 10.8 | $54M | 4.2M | 12.74 |
|
|
| Cullinan Oncology (CGEM) | 10.0 | $50M | -14% | 2.9M | 17.04 |
|
| Pliant Therapeutics (PLRX) | 8.9 | $45M | 3.0M | 14.90 |
|
|
| Engene Holdings (ENGN) | 8.3 | $42M | +99% | 2.5M | 16.95 |
|
| Tourmaline Bio (TRML) | 6.4 | $32M | +8% | 1.4M | 22.10 |
|
| Owl Rock Capital Corporation (OBDC) | 6.3 | $32M | 2.0M | 15.38 |
|
|
| Klaviyo Com Ser A (KVYO) | 6.1 | $31M | 1.2M | 25.48 |
|
|
| Larimar Therapeutics (LRMR) | 6.1 | $30M | +16% | 4.0M | 7.59 |
|
| Acelyrin (SLRN) | 3.8 | $19M | +23% | 2.8M | 6.75 |
|
| Evercommerce (EVCM) | 3.1 | $16M | NEW | 1.6M | 9.42 |
|
| Repare Therapeutics Ord (RPTX) | 2.9 | $15M | 3.1M | 4.71 |
|
|
| Ultragenyx Pharmaceutical (RARE) | 2.5 | $13M | 268k | 46.69 |
|
|
| Keros Therapeutics (KROS) | 2.3 | $11M | -51% | 173k | 66.20 |
|
| Inozyme Pharma (INZY) | 1.9 | $9.7M | 1.3M | 7.66 |
|
|
| Disc Medicine (IRON) | 1.9 | $9.7M | +10% | 155k | 62.26 |
|
| Sagimet Biosciences Com Ser A (SGMT) | 1.8 | $9.1M | +371% | 1.7M | 5.42 |
|
| Toast Cl A (TOST) | 1.6 | $8.0M | -94% | 323k | 24.92 |
|
| E2open Parent Holdings Com Cl A (ETWO) | 1.5 | $7.3M | 1.7M | 4.44 |
|
|
| Mineralys Therapeutics (MLYS) | 1.4 | $7.0M | -4% | 541k | 12.91 |
|
| Compass Therapeutics (CMPX) | 1.1 | $5.6M | 2.8M | 1.98 |
|
|
| Ikena Oncology (IKNA) | 1.1 | $5.5M | +99% | 3.9M | 1.42 |
|
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 1.0 | $5.0M | +53% | 100k | 50.23 |
|
| Dell Technologies SHS (DELL) | 0.9 | $4.7M | +17% | 41k | 114.11 |
|
| Omega Therapeutics Common Stock (OMGA) | 0.8 | $3.9M | 1.1M | 3.65 |
|
|
| Aquestive Therapeutics (AQST) | 0.7 | $3.7M | NEW | 875k | 4.26 |
|
| Direxion Shs Etf Tr Daily S&p Biotec (LABD) | 0.7 | $3.6M | +44% | 490k | 7.29 |
|
| Madrigal Pharmaceuticals (MDGL) | 0.7 | $3.6M | NEW | 13k | 267.04 |
|
| Black Diamond Therapeutics (BDTX) | 0.7 | $3.5M | 695k | 5.07 |
|
|
| Adc Therapeutics Sa SHS (ADCT) | 0.7 | $3.3M | 734k | 4.49 |
|
|
| Immunovant (IMVT) | 0.6 | $3.2M | +66% | 100k | 32.31 |
|
| Engene Holdings *w Exp 10/31/202 (ENGNW) | 0.5 | $2.7M | +7% | 511k | 5.20 |
|
| Ovid Therapeutics (OVID) | 0.5 | $2.6M | 865k | 3.05 |
|
|
| Starwood Property Trust SHS (BRZE) | 0.5 | $2.4M | +555% | 116k | 20.33 |
|
| Syros Pharmaceuticals Com New (SYRS) | 0.4 | $1.8M | -77% | 341k | 5.35 |
|
| Snowflake SHS (SNOW) | 0.3 | $1.3M | NEW | 7.8k | 161.60 |
|
| Gitlab (GTLB) | 0.2 | $1.2M | NEW | 21k | 58.32 |
|
| Blend Labs Cl A (BLND) | 0.2 | $1.2M | 362k | 3.25 |
|
|
| Gohealth Com Cl A (GOCO) | 0.2 | $875k | 83k | 10.51 |
|
|
| Desktop Metal Com Cl A (DM) | 0.1 | $660k | 750k | 0.88 |
|
|
| Rallybio Corp (RLYB) | 0.1 | $648k | 350k | 1.85 |
|
|
| Enliven Therapeutics (ELVN) | 0.1 | $440k | NEW | 25k | 17.59 |
|
| Precision Biosciences Com New | 0.1 | $274k | NEW | 20k | 13.56 |
|
| Fathom Digital Mfg Corp Cl A Com | 0.0 | $231k | 50k | 4.61 |
|
|
| Uber Technologies (UBER) | 0.0 | $79k | +286% | 24k | 3.30 |
|
| Plum Acquisition Corp Iii *w Exp 03/31/202 (PLMJW) | 0.0 | $0 | 667k | 0.00 |
|
Past Filings by Blue Owl Capital Holdings
SEC 13F filings are viewable for Blue Owl Capital Holdings going back to 2021
- Blue Owl Capital Holdings 2024 Q1 filed May 15, 2024
- Blue Owl Capital Holdings 2023 Q4 filed Feb. 15, 2024
- Blue Owl Capital Holdings 2023 Q3 filed Nov. 14, 2023
- Blue Owl Capital Holdings 2023 Q2 filed Aug. 11, 2023
- Blue Owl Capital Holdings 2023 Q1 filed May 11, 2023
- Blue Owl Capital Holdings 2022 Q4 filed Feb. 13, 2023
- Blue Owl Capital Holdings 2022 Q3 filed Nov. 14, 2022
- Blue Owl Capital Holdings 2022 Q2 filed Aug. 12, 2022
- Blue Owl Capital Holdings 2021 Q4 restated filed May 16, 2022
- Blue Owl Capital Holdings 2021 Q4 amended filed May 16, 2022
- Blue Owl Capital Holdings 2022 Q1 filed May 16, 2022
- Blue Owl Capital Holdings 2021 Q4 filed Feb. 11, 2022